|
1
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ebbesen KK, Hansen TB and Kjems J:
Insights into circular RNA biology. RNA Biol. 14:1035–1045. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kristensen LS, Hansen TB, Venø MT and
Kjems J: Circular RNAs in cancer: Opportunities and challenges in
the field. Oncogene. 37:555–565. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Weng W, Wei Q, Toden S, Yoshida K,
Nagasaka T, Fujiwara T, Cai S, Qin H, Ma Y and Goel A: Circular RNA
ciRS-7-A promising prognostic biomarker and a potential therapeutic
target in colorectal cancer. Clin Cancer Res. 23:3918–3928. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Horsham JL, Ganda C, Kalinowski FC, Brown
RA, Epis MR and Leedman PJ: MicroRNA-7: A miRNA with expanding
roles in development and disease. Int J Biochem Cell Biol.
69:215–224. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kishikawa T, Otsuka M, Yoshikawa T, Ohno
M, Yamamoto K, Yamamoto N, Kotani A and Koike K: Quantitation of
circulating satellite RNAs in pancreatic cancer patients. JCI
Insight. 1:e866462016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamagami M, Otsuka M, Kishikawa T, Sekiba
K, Seimiya T, Tanaka E, Suzuki T, Ishibashi R, Ohno M and Koike K:
ISGF3 with reduced phosphorylation is associated with constitutive
expression of interferon-induced genes in aging cells. NPJ Aging
Mech Dis. 4:112018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sekiba K, Yamagami M, Otsuka M, Suzuki T,
Kishikawa T, Ishibashi R, Ohno M, Sato M and Koike K:
Transcriptional activation of the MICA gene with an engineered
CRISPR-Cas9 system. Biochem Biophys Res Commun. 486:521–525. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoshikawa T, Wu J, Otsuka M, Kishikawa T,
Suzuki N, Takata A, Ohno M, Ishibashi R, Yamagami M, Nakagawa R, et
al: Repression of MicroRNA function mediates
inflammation-associated colon tumorigenesis. Gastroenterology.
152:631–643. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:2015. View Article : Google Scholar
|
|
15
|
Kramer MC, Liang D, Tatomer DC, Gold B,
March ZM, Cherry S and Wilusz JE: Combinatorial control of
Drosophila circular RNA expression by intronic repeats, hnRNPs, and
SR proteins. Genes Dev. 29:2168–2182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang N, Li X, Wu CW, Cai M, Mok MT, Wang
H, Chen J, Ng SS, Chen M, Sung JJ and Yu J: microRNA-7 is a novel
inhibitor of YY1 contributing to colorectal tumorigenesis.
Oncogene. 32:5078–5088. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Peng L, Yuan XQ and Li GC: The emerging
landscape of circular RNA ciRS-7 in cancer (Review). Oncol Rep.
33:2669–2674. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mezzadra R, Sun C, Jae LT, Gomez-Eerland
R, de Vries E, Wu W, Logtenberg MEW, Slagter M, Rozeman EA, Hofland
I, et al: Identification of CMTM6 and CMTM4 as PD-L1 protein
regulators. Nature. 549:106–110. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Burr ML, Sparbier CE, Chan YC, Williamson
JC, Woods K, Beavis PA, Lam EYN, Henderson MA, Bell CC, Stolzenburg
S, et al: CMTM6 maintains the expression of PD-L1 and regulates
anti-tumour immunity. Nature. 549:101–105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen DS, Irving BA and Hodi FS: Molecular
pathways: Next-generation immunotherapy-inhibiting programmed
death-ligand 1 and programmed death-1. Clin Cancer Res.
18:6580–6587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang W, Ji M, He G, Yang L, Niu Z, Jian M,
Wei Y, Ren L and Xu J: Silencing CDR1as inhibits colorectal cancer
progression through regulating microRNA-7. Onco Targets Ther.
10:2045–2056. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang J, Hu H and Zhao Y and Zhao Y:
CDR1as is overexpressed in laryngeal squamous cell carcinoma to
promote the tumour's progression via miR-7 signals. Cell Prolif.
51:e125212018. View Article : Google Scholar : PubMed/NCBI
|
